BSE Live
Apr 08, 16:01Prev. Close
104.20
Open Price
109.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 08, 15:42Prev. Close
108.97
Open Price
109.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Indo US Bio-Tech (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 4.18 | 4.45 | 4.23 | 2.66 | 2.42 | |
| Diluted EPS (Rs.) | 4.18 | 4.45 | 4.23 | 2.66 | 2.42 | |
| Cash EPS (Rs.) | 4.55 | 4.83 | 4.72 | 3.65 | 3.35 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 27.10 | 28.65 | 14.43 | 23.46 | 21.86 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 27.10 | 28.65 | 14.43 | 23.46 | 21.86 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 65.53 | 72.82 | 85.98 | 164.62 | 127.94 | |
| PBDIT/Share (Rs.) | 6.54 | 7.10 | 8.56 | 8.78 | 4.04 | |
| PBIT/Share (Rs.) | 6.19 | 6.61 | 8.06 | 7.79 | 3.11 | |
| PBT/Share (Rs.) | 4.74 | 5.79 | 5.96 | 3.50 | 1.62 | |
| Net Profit/Share (Rs.) | 4.18 | 4.30 | 4.23 | 2.66 | 2.42 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 9.98 | 9.75 | 9.95 | 5.33 | 3.15 | |
| PBIT Margin (%) | 9.45 | 9.07 | 9.37 | 4.73 | 2.42 | |
| PBT Margin (%) | 7.22 | 7.95 | 6.93 | 2.12 | 1.26 | |
| Net Profit Margin (%) | 6.37 | 5.90 | 4.92 | 1.61 | 1.88 | |
| Return on Networth / Equity (%) | 15.41 | 15.01 | 29.32 | 11.34 | 11.05 | |
| Return on Capital Employed (%) | 21.28 | 21.10 | 41.05 | 29.35 | 10.36 | |
| Return on Assets (%) | 7.30 | 8.74 | 8.45 | 3.15 | 2.62 | |
| Total Debt/Equity (X) | 0.48 | 0.39 | 1.26 | 1.39 | 1.43 | |
| Asset Turnover Ratio (%) | 114.59 | 148.07 | 171.73 | 195.42 | 139.17 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.87 | 2.45 | 1.47 | 1.27 | 1.18 | |
| Quick Ratio (X) | 1.34 | 1.21 | 0.87 | 0.67 | 0.65 | |
| Inventory Turnover Ratio (X) | 4.35 | 3.30 | 4.75 | 4.77 | 3.57 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 38.83 | 56.38 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.98 | 1.60 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 9.78 | 16.36 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.78 | 1.44 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 1.90 | 3.67 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.78 | 1.44 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.08 | 0.04 | 0.00 | 0.00 | 0.00 |
22.01.2026
Indo US Bio-Tec Standalone December 2025 Net Sales at Rs 22.80 crore, down 3.25% Y-o-Y
19.11.2025
Indo US Bio-Tec Standalone September 2025 Net Sales at Rs 30.85 crore, up 39.12% Y-o-Y
08.09.2025
Indo US Bio-Tec Standalone June 2025 Net Sales at Rs 30.77 crore, up 24.48% Y-o-Y
27.05.2025
Indo US Bio-Tec Standalone March 2025 Net Sales at Rs 33.38 crore, up 111.75% Y-o-Y
22.01.2026
Indo US Bio-Tec Standalone December 2025 Net Sales at Rs 22.80 crore, down 3.25% Y-o-Y
19.11.2025
Indo US Bio-Tec Standalone September 2025 Net Sales at Rs 30.85 crore, up 39.12% Y-o-Y
08.09.2025
Indo US Bio-Tec Standalone June 2025 Net Sales at Rs 30.77 crore, up 24.48% Y-o-Y
27.05.2025
Indo US Bio-Tec Standalone March 2025 Net Sales at Rs 33.38 crore, up 111.75% Y-o-Y
08.04.2026
08.04.2026
07.04.2026
07.04.2026
12.02.2026
Q3 results impact: Avanti Feeds, Apex Frozen shares rally up to 19% to fresh record highs
11.02.2026
Titan shares rise 3% to new 52-week high as Q3 results impress: Check brokerages' target prices
10.02.2026
Titan Q3 Results: Net profit rises 61% to Rs 1,684 crore on high gold prices, revenue up 43%
10.02.2026
BSE shares jump 6% to fresh record high after strong Q3 results: Brokerages raise target prices
23.01.2026
Matrimony Q3 PAT may dip 21.8% YoY to Rs. 7.8 cr: ICICI Securities
23.01.2026
India Mart Q3 PAT seen up 27.5% YoY to Rs. 154.3 cr: ICICI Securities
23.01.2026
Just Dial Q3 PAT seen up 17% YoY to Rs. 153.6 cr: ICICI Securities
23.01.2026
Nykaa Q3 PAT seen up 105.7% YoY to Rs. 53.7 cr: ICICI Securities